Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FUJRU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,679
Award facts
- Contract value 100% obligated
- $5,678.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $5,678.70 by the Defense Logistics Agency (DLA) for NUCALA 100 mg/ml auto-injectors. The contract, awarded on September 3, 2025, with an ultimate completion date of September 4, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at approximately $500 million and extends through November 2026.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group provides comprehensive pharmaceutical distribution services to Department of Defense healthcare facilities nationwide. The SPE2DB indefinite delivery vehicle enables the DLA to issue firm fixed-price delivery orders for an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, medical consumables, and specialty medications such as auto-injectors and injectable treatments. This particular order for NUCALA auto-injectors supports the medical supply needs of military health facilities and demonstrates DMS Pharmaceutical Group's continued role in delivering specialized pharmaceutical products to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FUJRU?
SPE2DB25FUJRU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FUJRU worth?
The government has obligated $5,679 on SPE2DB25FUJRU.
Is contract SPE2DB25FUJRU an order under another contract?
Yes. SPE2DB25FUJRU is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJRU competed?
The extent of competition for SPE2DB25FUJRU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award